Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Telstra (ASX:TLS) share price on watch on acquisition

The Telstra Corporation Ltd (ASX: TLS) share price is on watch after announcing that it’s making an acquisition.

Telstra’s new acquisition

Telstra said that its Telstra Health division has signed a binding agreement to acquire MedicalDirector for an enterprise value of $350 million.

The transaction is expected to be completed in the first quarter of FY22.

What is MedicalDirector?

MedicalDirector is a software company that provides GP clinic and practice management solutions. It reduces time spent on paperwork and administration and supports medical practitioners with patient medical records, electronic scripts virtual consultations, patient care plans and more.

It has been used by the medical industry for over 25 years and is currently used by around 23,000 medical practitioners.

Why Telstra thinks this is a good deal

Telstra said that this acquisition supports Telstra Health’s vision to be a leading partner for the health and aged care sectors.

Telstra plans to “significantly increase” investment in MedicalDirector to provide medical practitioners with the best digital solutions.

Management said it is “excited” to have the opportunity to grow MedicalDirector and combine its solutions with Telstra Health’s clinical and health system capabilities.

Telstra Health Board Chair Brendon Riley said: “GPs play a central role in connecting to every part of the health and aged care systems, and practice management is an incredibly important addition for Telstra Health in providing quality solutions and supporting them to deliver care.

“Telstra Health has transformed substantially over the past five years and this announcement reflects its continuing maturity as a business and its importance as part of Telstra’s long term growth strategy. It also reflects its continued growth into a global business, including strengthening our existing presence in the UK where MedicalDirector has been establishing itself in recent years.” 

Telstra share price

Rask Media ASX TLS Telstra share price
Source: Rask Media TLS 5-year share price

Summary thoughts on Telstra and the share price

It’s good to see that Telstra is focusing on growth and branching out globally into other sectors that compliment its telco business. Telstra might finally be turning things around, with its health division appearing to be a key part of its global growth strategy.

The acquisition of MedicalDirector for $350 million is not very large for a large business like Telstra, however Telstra also recently announced that it will buy a majority stake in global healthcare and hospital software provider PowerHealth.

Telstra has turned out to be a turbulent choice for investors and there might be a hearty dose of scepticism in the air about whether this finally is Telstra turn around story. However sentiment has been turning positive with the Telstra share price growing by 27% since the beginning of 2021.

At the time of writing the share price is up under 1% at $3.82.

There are many other ASX dividend shares I would be excited to buy before Telstra. I do hope this is the start of something good for Telstra shareholders and I’m watching along.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report — or get it emailed to you — for FREE by CLICKING HERE NOW or the button below.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content